Top videos
Get the best medical animation videos made at https://www.b2w.tv/healthcare-video-production
Check out more animated healthcare videos from out blog here https://www.b2w.tv/blog/health....care-marketing-video
Medical device manufacturers need to find new and innovative ways to explain their products to potential buyers.
It can be difficult for potential buyers to understand how a medical device works, and even more difficult to visualize how it would be used in a clinical setting.
Medical animation videos are the perfect way to showcase your medical devices.
They are engaging, easy to understand, and help potential buyers see how your product would fit into their workflow.
Jump to the video you like:
8. Pharming Healthcare 0:09
7. ThermoFisher Scientific 2:46
6. Fibrogen 5:49
5. OrthAlign 9:29
4. Edwards LifeSciences 11:34
3. Edwards LifeSciences 12:51
2. Edwards LifeSciences 13:43
1. Edwards LifeSciences 18:14
Check out more Healthcare Videos we have made for our clients:
1. Healthcare Explainer Video for WelbeHealth: https://on.b2w.tv/3OFRaWo
2. Healthcare Product Explainer Video for Edwards Lifesciences: https://on.b2w.tv/3OSdMDb
3. Healthcare Commercial Video for Coopervision: https://on.b2w.tv/45muvpf
4. Healthcare Marketing Video for OrthAlign: https://on.b2w.tv/3P8KBgD
5. Healthcare Video Marketing with The Video-First Approach: https://on.b2w.tv/3LiNDfW
6. 12 Best Brand Archetypes for Healthcare Videos: https://on.b2w.tv/3EIQ0Vu
Want to learn more about Healthcare Videos? Check out our blogs:
1. 10 Best Healthcare Marketing Videos: https://on.b2w.tv/47LxhpJ
2. 5 Animated Healthcare Commercial Videos: https://on.b2w.tv/47IgpAd
3. 11 Animated Healthcare Explainer Videos: https://on.b2w.tv/3Zd7fYM
4. How Long Does It Take To Make an Healthcare Explainer Video: https://on.b2w.tv/45nasak
5. Script for Healthcare Explainer Videos: https://on.b2w.tv/47IY1af
6. Guide to Making Your Own Healthcare Explainer Video: https://on.b2w.tv/3P6FKMR
#medicaldevice #medicalanimation #medicalanimations
Current treatment is a combination of pegylated interferon-alpha-2a or pegylated interferon-alpha-2b (brand names Pegasys or PEG-Intron) and the antiviral drug ribavirin for a period of 24 or 48 weeks, depending on hepatitis C virus genotype. In a large multicenter randomized control study among genotype 2 or 3 infected patients (NORDymanIC),[35] patients achieving HCV RNA below 1000 IU/mL by day 7 who were treated for 12 weeks demonstrated similar cure rates as those treated for 24 weeks.[36][37]
Pegylated interferon-alpha-2a plus ribavirin may increase sustained virological response among patients with chronic hepatitis C as compared to pegylated interferon-alpha-2b plus ribavirin according to a systematic review of randomized controlled trials .[38] The relative benefit increase was 14.6%. For patients at similar risk to those in this study (41.0% had sustained virological response when not treated with pegylated interferon alpha 2a plus ribavirin), this leads to an absolute benefit increase of 6%. About 16.7 patients must be treated for one to benefit (number needed to treat = 16.7; click here [39] to adjust these results for patients at higher or lower risk of sustained virological response). However, this study's results may be biased due to uncertain temporality of association, selective dose response.
Treatment is generally recommended for patients with proven hepatitis C virus infection and persistently abnormal liver function tests.
Treatment during the acute infection phase has much higher success rates (greater than 90%) with a shorter duration of treatment; however, this must be balanced against the 15-40% chance of spontaneous clearance without treatment (see Acute Hepatitis C section above).
Those with low initial viral loads respond much better to treatment than those with higher viral loads (greater than 400,000 IU/mL). Current combination therapy is usually supervised by physicians in the fields of gastroenterology, hepatology or infectious disease.
The treatment may be physically demanding, particularly for those with a prior history of drug or alcohol abuse. It can qualify for temporary disability in some cases. A substantial proportion of patients will experience a panoply of side effects ranging from a 'flu-like' syndrome (the most common, experienced for a few days after the weekly injection of interferon) to severe adverse events including anemia, cardiovascular events and psychiatric problems such as suicide or suicidal ideation. The latter are exacerbated by the general physiological stress experienced by the patient.
Stress-relaxation is a well-established mechanism for laboratory skin stretching, with limited clinical application in conventional suturing techniques due to the inherent, concomitant induction of ischemia, necrosis and subsequent suture failure. Skin defects that cannot be primarily closed are a common difficulty during reconstructive surgery. The TopClosure tension-relief system (TRS) is a novel device for wound closure closure, providing secured attachment to the skin through a wide area of attachment, in an adjustable manner, enabling primary closure of medium to large skin defects. The aim of this study was to evaluate the efficiency of the TopClosure TRS as a substitute for skin grafting and flaps for primary closure of large soft tissue defects by stress-relaxation. We present three demonstrative cases requiring resection of large to huge tumors customarily requiring closure by skin graft or flaps. TRS was applied during surgery serving as a tension-relief platform for tension sutures, to enable primary skin-defect closure by cycling of stress-relaxation, and following surgery as skin-secure system until complete wound closure. All skin defects ranging from 7 to 26 cm in width were manipulated by the TRS through stress-relaxation, without undermining of skin, enabling primary skin closure and eliminating the need for skin grafts and flaps. Immediate wound closure ranged 26 to 135 min. TRS was applied for 3 to 4 weeks. Complications were minimal and donor site morbidity was eliminated. Surgical time, hospital stay and costs were reduced and wound aesthetics were improved. In this case series we present a novel technology that enables the utilization of the viscoelastic properties of the skin to an extreme level, extending the limits of primary wound closure by the stress-relaxation principle. This is achieved via a simple device application that may aid immediate primary wound closure and downgrade the complexity of surgical procedures for a wide range of applications on a global scale.
Virtual Ports, Ltd. (http://www.virtual-ports.com) is a medical device company developing and marketing instruments to improve minimally invasive laparoscopic procedures.
The EndoGrab retraction system reduces the number of ports needed for surgery by eliminating the need for traditional hand held retraction. For the surgeon, this simple solution results in the need for less auxiliary personnel, a decreased overall surgery cost, and more control over the surgery. The EndoGrab also offers added benefit to the patient who will experience less post-operative discomfort and scarring.
The EndoGrab is an internally anchored, hands-free retracting device that is introduced at the start of surgery through a 5mm trocar by means of a proprietary Applier tool. The Surgeon uses the Applier to attach the EndoGrab to both the organ requiring retraction and to the internal abdominal wall, thereby removing the organ from the operative field. The Applier is then removed and the port is free for use by other instruments.
3D video animation produced by Virtual Point Multimedia (http://virtual-point.com)
Nasal polyps are soft, painless, noncancerous growths on the lining of your nasal passages or sinuses. They hang down like teardrops or grapes. They result from chronic inflammation due to asthma, recurring infection, allergies, drug sensitivity or certain immune disorders.
Flexible bronchoscopy is a procedure that allows a clinician to examine the breathing passages (airways) of the lungs (figure 1). Flexible bronchoscopy can be either a diagnostic procedure (to find out more about a possible problem) or a therapeutic procedure (to try to treat an existing problem or condition).
Antisocial personality disorder (ASPD) is defined by the American Psychiatric Association's Axis II (personality disorders) of the Diagnostic and Statistical Manual (DSM-IV-TR) as "a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood." Antisocial personality disorder is sometimes wrongly referred to as psychopathy or sociopathy. Currently, neither psychopathy nor sociopathy are valid diagnoses described in the Diagnostic and Statistical Manual of Mental Disorders, and the ICD-10 of the World Health Organization also lacks psychopathy as a diagnostic disorder. Psychopathy is normally seen as a subset of the antisocial personality disorder, but Blair believes that the antisocial personality disorder and psychopathy may be separate conditions altogether.
Nose cautery can help prevent nosebleeds. The doctor uses a chemical swab or an electric current to cauterize the inside of the nose. This seals the blood vessels and builds scar tissue to help prevent more bleeding. For this procedure, your doctor made the inside of your nose numb.
The most common symptoms of pneumoconiosis are cough and shortness of breath. The risk is generally higher when people have been exposed to mineral dusts in high concentrations and/or for long periods of time. Inadequate or inconsistent use of personal protective equipment (PPE) such as respirators (specially fitted protective masks) is another risk factor since preventing dusts from being inhaled will also prevent pneumoconiosis. Pneumoconiosis does not generally occur from environmental (non-workplace) exposures since dust levels in the environment are much lower.
Knee pain location can often tell you what type of knee pain you have. If you confirm that with common symptoms and what aggravates it… you can get a pretty good idea of ‘why my knee hurts’. So, here’s a quick look at the most common type of knee problems.
‘The 3 Essential Exercises EVERYONE Should Do’ … Watch this EXCLUSIVE video, only here: https://stefan-becker.mykajabi.com/3-essentials
QUESTIONS? I answer questions here now: I’ve started a Facebook Group to help people achieve their musculo-skeletal goals. Join here… https://www.facebook.com/groups/bodyfixexercises
AND I’m developing a Coaching Program! Over 12 weeks, I help people with posture related issues—like neck, shoulder, & upper back pain—discover their root problem and correct it using science-backed mobilising, stretching, & strengthening exercises… so they can feel straight, strong, flexible, & pain free again (and get back to doing what they love). Find out more, and join the wait list here… https://stefan-becker.mykajabi.com/waiting-list
0:00 Intro
0:11 Pain at the front of the knee (Pain in kneecap)
0:42 Pain below kneecap
1:40 Pain on inside of knee
3:05 Pain below knee on inside
3:29 Pain on outside of knee
3:28 Pain above knee
3:28 Pain behind knee
---------------------------------------
Mentioned in this video...
How To Fix Pain In The Front Of The Knee… (Runner's Knee) https://youtu.be/g0qmx_0enAA
Looking to stop your knee problems? Do this...
Knee Strengthening Exercises To Prevent Knee Pain
https://youtu.be/Pk-ae_lyx7M
How To Treat Patellar Tendinopathy (Jumper’s Knee) & Quadriceps Tendinopathy
https://youtu.be/MkPwsb-rQwU
---------------------------------------
If you’re asking yourself ‘what’s the cause of my knee pain?’ or ‘what kind of knee pain do I have?’ (so that you can look up solutions to your knee pain on YouTube) the position of your knee pain will tell you a lot.
THE MOST COMMON KNEE PAIN TYPES?
Knee pain during running (or actually kneecap pain while running) is usually just that… Runner’s Knee (PATELLOFEMORAL PAIN SYNDROME, or it’s old name: Chondromalacia Patella) If you get knee pain while cycling it will often be the same thing. Same with knee pain with stairs.
Knee pain while squatting could be Runner’s Knee, but if you get pain in the tendon below the kneecap, it’s more likely to be Patellar Tendonitis or Jumper’s Knee.
Meniscus Tears will give you pain on the inside of the knee that is a localised pain, can feel as if it gets stuck, or feel like it’s going to give way, and often it’s hard to fully straighten or fully bend your knee.
Knee pain on the outside of the knee is usually Iliotibial Band Syndrome
ALSO COVERED:
Infrapatellar Fat Pad Syndrome (Hoffa's Syndrome)
Osgood-Schlatter Disease
Medial Collateral Ligament Tear
Iliotibial Band Syndrome
Osteoarthritic Knee Pain
Pes Anserine Bursitis.
Quadriceps Tendinopathy
Popliteus Strain
Baker’s Cyst
ACL Or PCL Tear/Rupture
------------------------------------
#bodyfixexercises #kneepainrelief #kneepain
Thrombosis of the venous channels in the brain is an uncommon cause of cerebral infarction relative to arterial disease, but it is an important consideration because of its potential morbidity. (See Prognosis.) Knowledge of the anatomy of the venous system is essential in evaluating patients with cerebral venous thrombosis (CVT), since symptoms associated with the condition are related to the area of thrombosis. For example, cerebral infarction may occur with cortical vein or sagittal sinus thrombosis secondary to tissue congestion with obstruction. (See Presentation.) Lateral sinus thrombosis may be associated with headache and a pseudotumor cerebri–like picture. Extension into the jugular bulb may cause jugular foramen syndrome, while cranial nerve palsies may be seen in cavernous sinus thrombosis as a compressive phenomenon. Cerebral hemorrhage also may be a presenting feature in patients with venous sinus thrombosis. (See Presentation.) Imaging procedures have led to easier recognition of venous sinus thrombosis (see the images below), offering the opportunity for early therapeutic measures. (See Workup.) Left lateral sinus thrombosis demonstrated on magn Left lateral sinus thrombosis demonstrated on magnetic resonance venography (MRV). This 42-year-old woman presented with sudden onset of headache. Physical examination revealed no neurologic abnormalities. View Media Gallery Axial view of magnetic resonance (MR) venogram dem Axial view of magnetic resonance (MR) venogram demonstrating lack of flow in transverse sinus. View Media Gallery The following guidelines for CVT have been provided by the American Heart Association and the American Stroke Association [1] : In patients with suspected CVT, routine blood studies consisting of a complete blood count, chemistry panel, prothrombin time, and activated partial thromboplastin time should be performed. Screening for potential prothrombotic conditions that may predispose a person to CVT (eg, use of contraceptives, underlying inflammatory disease, infectious process) is recommended in the initial clinical assessment. Testing for prothrombotic conditions (including protein C, protein S, or antithrombin deficiency), antiphospholipid syndrome, prothrombin G20210A mutation, and factor V Leiden can be beneficial for the management of patients with CVT. Testing for protein C, protein S, and antithrombin deficiency is generally indicated 2-4 weeks after completion of anticoagulation. There is a very limited value of testing in the acute setting or in patients taking warfarin. In patients with provoked CVT (associated with a transient risk factor), vitamin K antagonists may be continued for 3-6 months, with a target international normalized ratio of 2.0-3.0. In patients with unprovoked CVT, vitamin K antagonists may be continued for 6-12 months, with a target international normalized ratio of 2.0-3.0. For patients with recurrent CVT, venous thromboembolism (VTE) after CVT, or first CVT with severe thrombophilia (ie, homozygous prothrombin G20210A; homozygous factor V Leiden; deficiencies of protein C, protein S, or antithrombin; combined thrombophilia defects; or antiphospholipid syndrome), indefinite anticoagulation may be considered, with a target international normalized ratio of 2.0-3.0. For women with CVT during pregnancy, low-molecular-weight heparin (LMWH) in full anticoagulant doses should be continued throughout pregnancy, and LMWH or vitamin K antagonist with a target international normalized ratio of 2.0-3.0 should be continued for ≥6 weeks postpartum (for a total minimum duration of therapy of 6 months). It is reasonable to advise women with a history of CVT that future pregnancy is not contraindicated. Further investigations regarding the underlying cause and a formal consultation with a hematologist or maternal fetal medicine specialist are reasonable. It is reasonable to treat acute CVT during pregnancy with full-dose LMWH rather than unfractionated heparin. For women with a history of CVT, prophylaxis with LMWH during future pregnancies and the postpartum period is reasonable. Next: Etiology What to Read Next on Medscape Related Conditions and Diseases Quiz: Do You Know the Complications, Proper Workup, and Best Treatment Practices for Ischemic Stroke? Quiz: How Much Do You Know About Hypothyroidism? Quiz: Do You Know the Risk Factors, Symptoms, and Potential Treatments for Alzheimer Disease? Quiz: How Much Do You Know About Hypertension? Quiz: Test Your Knowledge of Epilepsy and Seizure-related Conditions A 25-Year-Old Man With Painless Diplopia NEWS & PERSPECTIVE Temporal Trends and Factors Associated With Diabetes Mellitus Among Patients Hospitalized With Heart Failure Watchful Waiting Tied to Worse Outcomes in LVAD Patients With Hemolysis Age of Transfused Blood Impacts Perioperative Outcomes Among Patients Who Undergo Major Gastrointestinal Surgery TOOLS Drug Interaction Checker Pill Identifier Calculators Formulary SLIDESHOW Chronic Alcohol Abuse: Complications and Consequences Most Popular Articles According to Neurologists DHA Supplements Linked to Less Progression to Alzheimer's in APOE4 Carriers Heading in Soccer Linked to CNS Symptoms 'Transient Smartphone Blindness' Misdiagnosed as Multiple Sclerosis? New Advances in Traumatic Brain Injury FDA Clears Deflazacort (Emflaza) for DMD View More Overview Background
Open reduction and internal fixation (ORIF) is surgery used to stabilize and heal a broken bone. You might need this procedure to treat your broken thighbone (femur). The femur is the large bone in the upper part of your leg. Different kinds of trauma can damage this bone, causing it to fracture into 2 or more pieces. This might happen to the part of the femur near your knee, near the middle of the femur, or in the part of the femur that forms part of your hip joint. In certain types of femur fractures, your femur has broken, but its pieces still line up correctly. In other types of fractures (displaced fractures), the trauma moves the bone fragments out of alignment. If you fracture your femur, you usually need ORIF to bring your bones back into place and help them heal. During an open reduction, orthopedic surgeons reposition your bone pieces during surgery, so that they are back in their proper alignment. This contrasts with a closed reduction, in which a healthcare provider physically moves your bones back into place without surgically exposing your bone.